Raymed Labs Ltd is in the business of providing ophthalmological productsBusiness Overview: RMIL manufactures formulations with advanced technologies focusing into Preservative free Ophthalmic dosage for Conjunctivitis and Glaucoma Patient care. It also manufactures other formulations which are converted from suspension to solution. Company has a range of over 80 products....
Cresanto Global's board approved the financial results for the quarter and half-year ended Sep 30, 2025. The company reported a loss of ₹0.85 Lakh for the quarter and ₹10.06 Lakh for the half-year.
Cresanto Global Limited has announced a board meeting on November 5, 2025, to approve financial results for the quarter and half-year ended September 30, 2025. Stay tuned for earnings.
Cresanto Global Limited has filed a petition with the National Company Law Tribunal (NCLT) in Allahabad. The company is seeking NCLT approval for the reduction of its share capital. This action signifies a corporate restructuring effort, which could potentially impact the company's equity structure and balance sheet. Investors should observe...
Cresanto Global Limited has confirmed its compliance with depositories regulations for the quarter ended September 30, 2025. The company certified that details of dematerialized securities were duly furnished to BSE. Their Registrar and Share Transfer Agent further confirmed that all securities received for dematerialization during this period were processed, confirmed...
